| |
Company
Roster
|
|
Total
Insiders : |
40 |
|
|
|
Total
Direct Shares :
|
2,272,501 |
|
|
Total
Indirect Shares :
|
2,504,643 |
| |
%
Held by Insiders:
|
42.35% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Scheinberg David A |
Director |
2024-01-22 |
10,582 |
2017-12-29 |
0 |
| Varian John |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
| Francomano Robert |
Chief Commercial Officer |
2024-01-22 |
40,918 |
2023-02-02 |
0 |
| Van Nostrand Robert L |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
| Kalin Katherine Bach |
Director |
2024-01-22 |
8,500 |
2023-02-02 |
0 |
| Stergiou Andelos M. |
President and CEO, Director |
2024-01-22 |
376,421 |
2017-12-29 |
0 |
| Wood Barbara A |
EVP, Gen. Counsel, Corp. Sec. |
2024-01-22 |
117,225 |
2020-03-12 |
0 |
| Wasman Jane |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
| Burns John Thomas |
CFO |
2024-01-22 |
101,927 |
|
0 |
| Eqc Private Markets Ii Sac Fund Ltd-Eqc Biotech Se |
10% Owner |
2018-09-24 |
0 |
2018-09-24 |
0 |
| Tafur Daniel |
10% Owner |
2017-12-29 |
0 |
2017-12-29 |
3,343 |
| Galliker Stephens S |
Director |
2017-10-10 |
36,039 |
|
0 |
| Ashton William |
Director |
2017-10-10 |
38,154 |
2017-01-20 |
0 |
| Hillsberg Sanford |
Director |
2017-10-10 |
56,950 |
2014-02-03 |
85,447 |
| Chin Richard |
Director |
2017-10-10 |
31,339 |
2014-01-30 |
0 |
| Gray Mary Ann |
Director |
2017-10-10 |
39,167 |
|
0 |
| Einhorn Irving M. |
Director |
2017-10-10 |
34,690 |
2017-01-20 |
0 |
| Nisi Rudolph |
Director |
2017-10-10 |
42,918 |
2009-10-16 |
0 |
| Gerber Sander |
10% Owner |
2017-02-08 |
0 |
2017-02-08 |
2,036,559 |
| Schwartz Mark W. |
President & CEO |
2016-07-01 |
439,978 |
2011-04-13 |
0 |
| Nejadnik Bijan |
Chief Medical Officer |
2016-07-01 |
8,503 |
2016-07-01 |
0 |
| Dunlap Ryan |
Former Chief Financial Officer |
2016-06-01 |
18,702 |
2012-12-31 |
0 |
| Hamilton Brian L |
EVP, Chief Medical Officer |
2014-06-30 |
2,461 |
2014-06-30 |
0 |
| Ahn Mark J |
President & CEO, Director |
2014-06-30 |
116,225 |
|
0 |
| Kriegsman Steven A |
Director |
2014-01-23 |
5,000 |
2008-03-11 |
0 |
| Lee Kwang |
Principal Accounting Officer |
2011-12-07 |
5,000 |
2011-12-07 |
0 |
| Khvorova Anastasia |
Former CSO |
2011-09-24 |
137,482 |
2010-01-20 |
0 |
| Kennedy Robert Eugene |
Vice President and CFO |
2011-04-13 |
374,288 |
2011-04-13 |
379,294 |
| Varanasi Ramani |
VP Business Development |
2011-03-15 |
41,083 |
2010-01-20 |
0 |
| Beerman Noah D |
CEO and President, Director |
2011-03-15 |
92,994 |
2010-01-20 |
0 |
| Pavco Pamela |
VP of Pharmaceutical Devlpmt |
2011-03-15 |
44,940 |
2010-01-20 |
0 |
| Tata Amy B |
Principlw Acctg Officer & Cont |
2011-03-15 |
14,065 |
2011-03-15 |
0 |
| Cytrx Corp |
10% Owner |
2010-12-29 |
0 |
|
0 |
| Samarsky Dmitry |
VP, Technology Development |
2010-03-31 |
0 |
2010-01-20 |
0 |
| Andrikopoulos Konstantinos |
VP, Legal |
2010-01-20 |
5,750 |
2010-01-20 |
0 |
| Mack Gene |
|
|
0 |
|
0 |
| Kivinski Margaret |
|
|
0 |
|
0 |
| Sarlis Nicholas J. |
|
|
0 |
|
0 |
| Torre Gregory M |
|
|
0 |
|
0 |
| Lopez Fabio |
|
|
0 |
|
0 |
|
0.03 (2.26%) 
